
Cybin Inc.
CYBN.NENEOHealthcare● Active
$5.65
$-0.13(-2.25%)
Market Cap$136762657
P/E Ratio—
52W High$15.27
52W Low$5.64
Cybin Inc.(CYBN.NE)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CYBN.NE · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B |
| Gross Margin %(computed) | — | — | — | — | 23.15% |
| Operating Expenses | |||||
| R&D Expenses | $0.05B | $0.03B | $0.03B | $0.02B | $0.00B |
| G&A Expenses | $0.08B | $0.04B | $0.03B | $0.04B | $0.03B |
| Total Operating Expenses | $0.14B | $0.08B | $0.05B | $0.06B | $0.03B |
| Operating Income | ($0.14B) | ($0.08B) | ($0.05B) | ($0.06B) | ($0.03B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.11B) | ($0.08B) | ($0.05B) | ($0.07B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Income | ($0.11B) | ($0.08B) | ($0.05B) | ($0.07B) | ($0.03B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.61 | $-9.50 | $-0.26 | $-0.40 | $-12.16 |
| Wtd Avg Shares | 0.19B | 0.01B | 0.19B | 0.17B | 0.10B |
| EBITDA | ($0.14B) | ($0.08B) | ($0.05B) | ($0.06B) | ($0.03B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · CAD · B
深入了解Cybin Inc.
关于Cybin Inc.(CYBN.NE)损益表
Cybin Inc.(CYBN.NE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CYBN.NE实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.11B)(净利率—)。
常见问题
CYBN.NE · 4 问Cybin Inc.(CYBN.NE)2025财年营收为$0.00B,同比down—%。
CYBN.NE revenueCYBN.NE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08